Philips Finalizes Two Hundred Eighty-Eight Million Euro Settlement for Defective Sleep Apnea Devices
The Dutch health technology multinational Philips has agreed to pay two hundred eighty-eight million euros to resolve remaining regulatory claims in the United States, removing a major legal burden and allowing corporate leadership in Amsterdam to focus on healthcare innovation.